KRC-01

DRUG2 trials

Sponsors

Institut Gustave Roussy, Kortuc, Inc.

Conditions

Cervical CancerLocally advanced high‑risk stage III rectal adenocarcinoma (non‑metastatic)

Phase 1

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

RecruitingNCT05570422

Kortuc, Inc.Cervical Cancer

Start: 2026-03-01End: 2027-03-30Target: 70Updated: 2026-04-08

Phase 2

Phase II Clinical Trial of KORTUC (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer: Towards a New Organ Preservation Approach (K-BOOST)

Not yet recruitingCTIS2025-524378-40-00

Institut Gustave RoussyLocally advanced high‑risk stage III rectal adenocarcinoma (non‑metastatic)

Target: 24Updated: 2026-05-29